for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BioSpecifics Technologies Corp.

BSTC.OQ

Latest Trade

48.78USD

Change

-0.56(-1.13%)

Volume

17,582

Today's Range

48.02

 - 

49.40

52 Week Range

48.02

 - 

73.31

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Biospecifics Technologies Names J. Kevin Buchi As CEO

Oct 10 (Reuters) - Biospecifics Technologies Corp <BSTC.O>::BIOSPECIFICS TECHNOLOGIES CORP. NAMES J. KEVIN BUCHI AS CHIEF EXECUTIVE OFFICER.BIOSPECIFICS TECHNOLOGIES CORP - KEVIN BUCHI WILL ALSO SERVE ON COMPANY'S BOARD OF DIRECTORS.BIOSPECIFICS TECHNOLOGIES CORP - BUCHI IS CURRENTLY CHAIRMAN OF BOARD OF DIRECTORS AT DICERNA PHARMACEUTICALS.

Biospecifics Technologies Q2 Earnings Per Share $0.87

Aug 9 (Reuters) - Biospecifics Technologies Corp <BSTC.O>::. REPORTS SECOND QUARTER 2019 FINANCIAL AND OPERATING RESULTS.Q2 EARNINGS PER SHARE $0.87.Q2 REVENUE $8.9 MILLION VERSUS $7.9 MILLION.BIOSPECIFICS TECHNOLOGIES - AS OF JUNE 30, 2019, HAD CASH AND CASH EQUIVALENTS & INVESTMENTS OF $93.5 MILLION, VERSUS $82.0 MILLION AS OF DEC 31, 2018.

Biospecifics Technologies Corp Reports First Quarter 2019 Financial And Operating Results

May 10 (Reuters) - Biospecifics Technologies Corp <BSTC.O>::REPORTS FIRST QUARTER 2019 FINANCIAL AND OPERATING RESULTS.Q1 EARNINGS PER SHARE $0.60.Q1 REVENUE $8.1 MILLION VERSUS $7.1 MILLION.QTRLY TOTAL REVENUES $8.1 MILLION VERSUS $7.1 MILLION.

Biospecifics Technologies Corp Reports Q4 Earnings Per Share $0.84

April 2 (Reuters) - Biospecifics Technologies Corp <BSTC.O>::. REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS.Q4 EARNINGS PER SHARE $0.84.Q4 REVENUE ROSE 48 PERCENT TO $9.9 MILLION.BIOSPECIFICS TECHNOLOGIES - AS OF DEC 31, 2018, HAD CASH AND CASH EQUIVALENTS AND INVESTMENTS OF $82.0 MILLION, COMPARED TO $65.1 MILLION AS OF DEC 31, 2017.

Biospecifics Technologies Corp Announces Passing Of President Thomas Wegman

March 18 (Reuters) - Biospecifics Technologies Corp <BSTC.O>::BIOSPECIFICS TECHNOLOGIES CORP. ANNOUNCES PASSING OF PRESIDENT THOMAS L. WEGMAN.BIOSPECIFICS TECHNOLOGIES CORP - WILL CONTINUE TO BE ACTIVELY MANAGED BY ITS CURRENT EMPLOYEES AND BOARD OF DIRECTORS.BIOSPECIFICS TECHNOLOGIES CORP - SUCCESSION PLANNING IS UNDERWAY AND NEW MANAGEMENT POSITIONS WILL BE ANNOUNCED.

BioSpecifics Technologies Reports Q3 Earnings Per Share $0.69

Nov 9 (Reuters) - Biospecifics Technologies Corp <BSTC.O>::BIOSPECIFICS TECHNOLOGIES CORP. REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 EARNINGS PER SHARE $0.69.Q3 REVENUE $8.2 MILLION VERSUS $6.5 MILLION.

BioSpecifics Technologies Announces Positive Topline Results From Phase 1 Study Of CCH

Oct 31 (Reuters) - BioSpecifics Technologies Corp <BSTC.O>::BIOSPECIFICS TECHNOLOGIES CORP. ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 1 STUDY OF CCH FOR THE TREATMENT OF UTERINE FIBROIDS.BIOSPECIFICS TECHNOLOGIES - CCH PHASE 1 STUDY MET PRIMARY ENDPOINT OF SAFETY AND TOLERABILITY WITH NO OBSERVED CLINICALLY SIGNIFICANT ADVERSE REACTIONS.BIOSPECIFICS TECHNOLOGIES CORP - FAVORABLE SAFETY AND TOLERABILITY CONSISTENT WITH CCH CLINICAL TRIALS TO DATE.

Biospecifics Technologies Reports Q2 Earnings Per Share $0.59

Aug 9 (Reuters) - Biospecifics Technologies Corp <BSTC.O>::BIOSPECIFICS TECHNOLOGIES CORP REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 EARNINGS PER SHARE $0.59.Q2 REVENUE $7.1 MILLION VERSUS $6.5 MILLION.BIOSPECIFICS IS AUTHORIZED TO REPURCHASE UP TO $3.0 MILLION OF ITS OUTSTANDING COMMON STOCK.

Biospecifics Technologies Reports Q1 Earnings Per Share $0.54

May 9 (Reuters) - Biospecifics Technologies Corp <BSTC.O>::BIOSPECIFICS TECHNOLOGIES CORP. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 EARNINGS PER SHARE $0.54.Q1 REVENUE $7.1 MILLION VERSUS $7.7 MILLION.BIOSPECIFICS - AS OF MARCH 31, 2018, CO HAD CASH AND CASH EQUIVALENTS AND INVESTMENTS OF $64.2 MILLION, COMPARED TO $65.1 MILLION AS OF DEC 31, 2017.BIOSPECIFICS - CO'S CASH, CASH EQUIVALENTS WERE SLIGHTLY LOWER DUE TO THE TIMING OF ENDO'S PAYMENT OF ITS QTRLY XIAFLEX ROYALTIES.

Biospecifics Technologies Q4 Earnings Per Share $0.36

March 14 (Reuters) - Biospecifics Technologies Corp <BSTC.O>::. REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 EARNINGS PER SHARE $0.36.‍TOTAL REVENUE FOR Q4 ENDED DECEMBER 31, 2017 WAS $6.7 MILLION, COMPARED TO $6.6 MILLION FOR SAME PERIOD IN 2016​.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up